Disposition of Posaconazole following Single-Dose Oral Administration in Healthy Subjects

Posaconazole is a potent, broad-spectrum triazole antifungal agent currently in clinical development for the treatment of refractory invasive fungal infections. Eight healthy male subjects received a single 399-mg (81.7 μCi) oral dose of [(14)C]posaconazole after consuming a high-fat breakfast. Urin...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Main Authors: Krieter, Philip, Flannery, Brian, Musick, Timothy, Gohdes, Mark, Martinho, Monika, Courtney, Rachel
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology (ASM) 2004
Assuntos:
Pharmacology
Acceso en liña:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC514780/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15328123/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.9.3543-3551.2004
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares